home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops

Search

 
  IBC's CMC Regulatory Compliance of Biopharmaceuticals  
  May 09, 2003

Others

 
     
  IBC Life Sciences, Embassy Suites, San Diego, CA
July 14-15, 2003


With the constant changing landscape of the biopharmaceutical industry, coupled with ongoing changes in the CMC compliance regulations, it has become increasingly important to be able to identify and effectively respond to the CMC issues. At each stage of clinical trial development the basic question will be addressed: 'What do we absolutely have to do from a CMC perspective to be successful in getting our biopharmaceutical through the clinical trials and into the market?' While the focus is on FDA requirements, global CMC issues involving EMEA and ICH are also discussed.
 
 
Organized by: IBC Life Sciences
Invited Speakers: Course Instructor:
John Geigert, Ph.D., RAC President, BioPharmaceutical Quality Solutions
 
Deadline for Abstracts: -
 
Registration: Phone: (508) 616-5550 x1004 Fax: (508) 616-5533 Email: reg@ibcusa.com Online: www.LifeSciencesInfo.com/2891 Mail IBC USA Conferences, Inc. One Research Drive Suite 400A Westborough, MA 01581-5195
E-mail: reg@ibcusa.com
 
  Posted by:   James G. Prudhomme  
Host: host-65-124-112-226.ibcusa.com
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.